LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set— 510(k) K162969
Substantially EquivalentDiaSorin, Inc.
FDA 510(k) clearance K162969 for LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control Set, Substantially Equivalent on 2017-01-06. Applicant: DiaSorin, Inc..
Clearance details
- Applicant
- DiaSorin, Inc.
- Product code
- Code LFZ
- Advisory panel
- Microbiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Special
- Location
- Stillwater, MN, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.